Handbook of Lipids in Human Function: Fatty Acids presents current research relating to health issues whose impact may be modified by adopting personalized diets and lifestyle interventions of the consumption of fatty acids. Addressing cardiovascular and neurological diseases as well as cancer, obesity, inflammatory conditions, and lung disease, the authors correlate lipid sources with specific conditions, providing important insights into preventative as well as response-based actions designed to positively impact health outcomes.
The material is presented in 29 chapters and brings together the research and work of an international team of experts. designed to bridge the gap between traditional approaches to dietary interventions and leading edge integrated health strategies, Handbook of Lipids in Human Function: Fatty Acids is a valuable resource for researchers and clinicians.
- Discusses the importance of essential fatty acids in maintaining cardio- and cerebro-vascular health
- Explains the metabolic risks associated with deficiencies and/or imbalance of essential fatty acids
- Explores the promise of essential fatty acids as adjuvants to pharmacopoeia
- Suggests interventions with personalized lipid diets
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Chapter 2: Trans Fats and Risks of Cardiovascular Diseases: Facts or Artifacts?
Chapter 3: Fatty Acids and Cardiac Ischemia Reperfusion Injury
Chapter 4: Lipids Nutrition and Epigenetic Modification in Obesity-Related Co-Morbitities
Chapter 5: Dairy Products: Their Role in the Diet and Effects on Cardiovascular Disease
Chapter 6: Fatty Acids in Corn Oil: Role in Heart Disease Prevention
Chapter 7: Dietary Approaches to Reduce Aortic Stiffness
Chapter 8: Inflammation and Atherogenic Effects Due to Saturated Fatty Acids
Chapter 9: The Use of Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Atrial Fibrillation
Chapter 10: Individual Fatty Acids in Cardiometabolic Disease
Chapter 11: Omega-3 Polyunsaturated Fatty Acids in Patients with Coronary Disease Treated with Percutaneous Coronary Intervention
Chapter 12: Effects of Omega-3 Fatty Acid Supplementation on Cognition in Children
Chapter 13: The Effects of Glycerophospholipids and Fatty Acids on APP Processing: Implications for Alzheimer's Disease
Chapter 14: Role of Dietary Fatty Acids in Mood Disorders
Chapter 15: Biochemical Aspects of n-6 and n-3 Fatty Acid-Derived Lipid Mediators in the Brain
Chapter 16: Neurocognitive Functions and Lipids
Chapter 17: What Are the Physiological Roles of Mead Acid (5,8,11-Eicosatrienoic Acid)?
Chapter 18: Fat Metabolism During Exercise and Dietary Interventions for Enhancing Fat Metabolism and Athletic Performance
Chapter 19: Ruminal Metabolism of Fatty Acids: Modulation of Polyunsaturated, Conjugated, and Trans Fatty Acids in Meat and Milk
Chapter 20: Lipids and Metabolic Syndrome
Chapter 21: Fatty Acids and Hypothalamic Dysfunction in Obesity
Chapter 22: Dietary Lipid Determines the Health of Airway Epithelia and the Lungs
Chapter 23: Oleic Acid and Lung Injury
Chapter 24: Dietary Fats and Inflammation
Chapter 25: Intensive Lipid-Lowering Treatment in Patients with Inflammatory Joint Diseases
Chapter 26: Arachidonic Acid and Cancer Risk
Chapter 27: Blood Cell Membrane Omega-3 (n-3) Fatty Acid Abnormality and Supplementation in Patients with Sickle Cell Anemia
Chapter 28: Lipids, Low-Grade Chronic Inflammation and NAFLD: A Menage A Trois?
Chapter 29: Disturbances of Lipid Metabolism in a Cancer Cell and How This Knowledge Increases Its Role in Clinical Oncology
Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson's career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models.
De Meester, Fabien
Fabien De Meester PhD is a biochemist, owner and managing director of DMF, a company invested in the promotion of body/mind health at people management levels. His long expertise in protein and lipid chemistry derives from his day-to-day consulting activities within enterprises around the world. It provides him with the visionary approach needed to implement changes in use and importance of fatty acids.